Form 4: Q32 Bio Inc. Executive Shelia M. Violette Reports Stock Option Exercises and Resulting Share Ownership Changes
SEC Form 4 Filing
Shelia M. Violette, Chief Scientific Officer of Q32 Bio Inc., reports exercising stock options and subsequent changes in beneficial ownership of common stock.
Summary
- On October 11, 2024, Shelia M. Violette exercised stock options to acquire 4,574 shares of Q32 Bio Inc. common stock at a price of $3.12 per share.
- On October 15, 2024, she exercised additional stock options to acquire 6,000 shares at $7.29 per share.
- Following these transactions, Ms. Violette directly owns 23,874 shares of common stock.
- She also indirectly owns 36,277 shares through Violette Holdings LLC.
- The report clarifies that Ms. Violette disclaims beneficial ownership of the shares held by Violette Holdings LLC except to the extent of her pecuniary interest.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it is a standard disclosure of stock option exercises. It doesn't inherently indicate positive or negative performance of the company.
Industry Context
Form 4 filings are standard disclosures required by the SEC to provide transparency regarding insider transactions in publicly traded companies. This filing indicates changes in the holdings of a key executive at Q32 Bio Inc.
Stakeholder Impact
- Shareholders are informed about changes in ownership by a key executive.
- The filing provides transparency regarding insider transactions.
Key Dates
| Date | Description |
|---|---|
| 12/02/2020 | Date from which stock options vest and become exercisable in sixteen (16) equal quarterly installments. |
| 10/11/2024 | Date of stock option exercise at $3.12 per share. |
| 10/15/2024 | Date of stock option exercise at $7.29 per share. |
| 10/16/2024 | Date of report filing. |
| 12/06/2028 | Expiration date for some stock options. |
| 12/01/2030 | Expiration date for some stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.